Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Ozpolat

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Plos One|October 1, 2014
Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsNilgun Gurbuz, Ahmed A Ashour, S Neslihan Alpay, et al.
Plos One|August 30, 2014
Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsNilgun Gurbuz, Ahmed A Ashour, S Neslihan Alpay, et al.
Autophagy|March 13, 2010
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancerKevin N Dalby, Ibrahim Tekedereli, Gabriel Lopez-Berestein, et al.
Molecular and Cellular Biochemistry|January 30, 2021
UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cellsSevide Sencan, Mine Tanriover, Mustafa Ulasli, et al.
Experimental and Molecular Pathology|January 22, 2021
Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cellsHakan Soylu, Mustafa Kırca, Sema Avcı, et al.
Cellular Signalling|February 4, 2021
Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancerMumin Alper Erdogan, Ahmed Ashour, Erkan Yuca, et al.
International Journal of Cancer|May 2, 2009
Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemiaPablo E Vivas-Mejía, Bulent Ozpolat, Xian Chen, et al.
Future Medicinal Chemistry|July 2, 2025
New and potential boron-containing compounds for treatment of Alzheimer's disease and cancersFerah Comert Onder, Kadircan Ural, Alper Onder, et al.
RSC Medicinal Chemistry|August 4, 2022
Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapyFerah Comert Onder, Pinar Siyah, Serdar Durdagi, et al.
Cell Biochemistry and Biophysics|September 12, 2025
Boron Containing Curcumin-Like Compound as an Acetylcholinesterase Inhibitor and Anticancer Agent: Synthesis, Biological Evaluation, and Computational InsightsFerah Comert Onder, Kadircan Ural, Alper Onder, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Plos One|October 1, 2014
Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsNilgun Gurbuz, Ahmed A Ashour, S Neslihan Alpay, et al.
Plos One|August 30, 2014
Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsNilgun Gurbuz, Ahmed A Ashour, S Neslihan Alpay, et al.
Autophagy|March 13, 2010
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancerKevin N Dalby, Ibrahim Tekedereli, Gabriel Lopez-Berestein, et al.
Molecular and Cellular Biochemistry|January 30, 2021
UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cellsSevide Sencan, Mine Tanriover, Mustafa Ulasli, et al.
Experimental and Molecular Pathology|January 22, 2021
Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cellsHakan Soylu, Mustafa Kırca, Sema Avcı, et al.
Cellular Signalling|February 4, 2021
Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancerMumin Alper Erdogan, Ahmed Ashour, Erkan Yuca, et al.
International Journal of Cancer|May 2, 2009
Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemiaPablo E Vivas-Mejía, Bulent Ozpolat, Xian Chen, et al.
Future Medicinal Chemistry|July 2, 2025
New and potential boron-containing compounds for treatment of Alzheimer's disease and cancersFerah Comert Onder, Kadircan Ural, Alper Onder, et al.
RSC Medicinal Chemistry|August 4, 2022
Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapyFerah Comert Onder, Pinar Siyah, Serdar Durdagi, et al.
Cell Biochemistry and Biophysics|September 12, 2025
Boron Containing Curcumin-Like Compound as an Acetylcholinesterase Inhibitor and Anticancer Agent: Synthesis, Biological Evaluation, and Computational InsightsFerah Comert Onder, Kadircan Ural, Alper Onder, et al.
Pageof 14